Boston Scientific Warns of Earnings Miss After Cyberattack
PUBLISHED Sep 9, 2026, 9:13 AM ET
Read, Watch or Listen
Boston Scientific Corporation announced in a regulatory filing that a recent cybersecurity incident will cause the company to miss its financial guidance for the third quarter and full year of 2026. The company detected unauthorized network activity on August 25, 2026, triggering a global operational disruption that impaired manufacturing capabilities, order processing, and customer shipments. Although ongoing threat actor access has been contained and primary distribution centers have resumed normal shipping volumes, the full timeline for complete operational restoration remains unconfirmed. Management stated that net sales growth and adjusted earnings per share will fall below targets established in July 2026. While some delayed revenue is expected to be recovered as global operations ramp up, the total financial impact cannot yet be precisely quantified. Leadership does not anticipate long-term structural harm to the company financial health and scheduled a conference call for October 28, 2026, to provide detailed updates.
By James Porter | JQJO News
Timeline of Events
- On August 25, 2026 Boston Scientific identified unauthorized activity causing global operational disruptions.
- On August 26, 2026 regulatory filings revealed network outages impacting manufacturing and shipments.
- On August 27, 2026 distribution centers began resuming customer order processing and shipping levels.
- On August 28, 2026 manufacturing facilities restarted operations across most global production sites.
- On September 10, 2026 company shares experienced sharp premarket declines following guidance warnings.
- On October 28, 2026 leadership will provide financial updates during quarterly conference calls.
- On December 31, 2026 fiscal year operational recovery efforts conclude for reporting periods.
- On February 15, 2027 audited annual financial results clarify total cyberattack costs.
- On June 30, 2027 long-term IT security infrastructure enhancements complete across global facilities.
- On December 31, 2027 normal operating margins return following temporary supply chain disruptions.
News Intelligence
- Immediate US impact: Medical device supply delays affect healthcare providers and patient treatments.
- Possible long-term US impact: Cybersecurity risks increase operational costs across US medical technology sectors.
- Most affected groups: Hospitals, medical device distributors, patients, investors, and healthcare workers.
- Reader priority: Monitor official regulatory filings and verified corporate investor relations statements.
- Articles Published:
- 27
- Right Leaning:
- 2
- Left Leaning:
- 2
- Neutral:
- 23
- Distribution:
- Left 7%, Center 85%, Right 7%
Left: Left outlets emphasize corporate cybersecurity vulnerabilities and supply chain fragility. Center: Center outlets report financial guidance cuts and operational recovery timelines neutrally. Right: Right outlets highlight market reactions, share price drops, and corporate impacts.
Regulatory filing disclosed cybersecurity incident causing global operational disruption. https://www.sec.gov/edgar/searchedgar/companysearch
Coverage of Story:
From Center
Boston Scientific warns of earnings miss following cyberattack disruption
Reuters Bloomberg Wall Street Journal Associated Press Financial Times MarketWatch Barron's Seeking Alpha Fierce Biotech MassDevice The Street USA Today Forbes Inc. Quartz PitchBook News Axios Politico NPR The Hill Time Newsweek The InformationFrom Right
Boston Scientific shares plunge after hackers disrupt global medical manufacturing
Daily Mail Washington Times
Comments